Article
type: Class

http://irises.unibs.it/resource/item/26684
type: Continuant
type: Information Content Entity
most specific type: Academic Article
type: Thing
type: Document
type: Academic Article
type: Generically Dependent Continuant
type: Article
label: Ranitidine bismuth citrate (RBC) based triple therapy for 7 days is more effective than RBC plus clarithromycin for 14 days in dyspeptic patients with Helicobacter pylori infection. H. Pylori Lombardy Group
language: Inglese
type: Entity

Document
type: Class

Information Content Entity
type: Class

Academic Article
type: Class

Continuant
type: Class

Inglese
type: Language

Entity
type: Class

Generically Dependent Continuant
type: Class

individual
rights: termsOfUse
date: 2026-08-24T09:12:24
publisher: http://irises.unibs.it/resource/item/26684
type: Document
label: RDF description of Ranitidine bismuth citrate (RBC) based triple therapy for 7 days is more effective than RBC plus clarithromycin for 14 days in dyspeptic patients with Helicobacter pylori infection. H. Pylori Lombardy Group - http://irises.unibs.it/resource/item/26684